Clinical Trial Update: Study of ONO-8577 in Patients With Overactive Bladder [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ONO-8577 in patients with Overactive Bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• ONO-8577

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED